SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is trending following a launch failure where Blue Origins rocket placed the BlueBird 7 satellite into an unusable, off-nominal orbit, prompting investors to debate the company's reliance on launch partners versus its long-term commercial potential. While some in the community see the sharp sell-off as a strategic buying opportunity due to insurance coverage and intact fundamentals, others are expressing frustration over management's communication and the potential impact on future launch cadence.

RaveDAO is a global community uniting music, technology, and purpose. Since their first sold-out event at Dubai 2024, they have expanded across Europe, the Middle East, North America, and Asia, hosting world-class experiences with over 100,000 total attendees and 3,000+ attendees for each event.  RaveDAO has worked with top-tier artists like Vintage Culture, Don Diablo, Chris Avantgarde, Lilly Palmer, MORTEN, Bassjackers, and GENESI and has support from Binance, OKX, Bitget, and Polygon. RaveDAO is redefining live entertainment in Web3 and has active partnerships with 1001Tracklists, AMF, and Warner Music.  Beyond the dance floor, RaveDAO channels energy and attention toward impact. In 2025 alone, proceeds from its events helped restore sight to 400+ cataract patients in Nepal and fund over 150 meditation programs across the U.S.

RaveDAO

RaveDAO is experiencing extreme volatility as investors clash over whether the recent price surge represents a legitimate breakout tied to global event expansion or a classic pump-and-dump scheme. The community is deeply divided, with some traders highlighting successful price action while others aggressively warn of manipulation, potential rug-pull risks, and the dangers of chasing hype in the memecoin space.

Newcourt Acquisition Corp. is a blank check company, which engages in the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on February 25, 2021 and is headquartered in Oakland, CA.

Psyence Biomedical Ltd.

Psyence Biomedical is experiencing massive volatility and high trading volume as investors chase speculative gains fueled by an executive order to fast-track psychedelic research. The community is sharply divided, with bulls betting on a short squeeze due to a limited float and potential government support, while bears warn of pump-and-dump mechanics, potential dilution, and a lack of direct clinical data connecting the stock to the reported ibogaine catalyst.

Marvell Technology, Inc. engages in the design, development, and sale of integrated circuits. Its products include data processing units, security solutions, automotive, coherent DSP, DCI optical modules, ethernet controllers, ethernet PHYs, ethernet switches, linear driver, PAM DSP, transimpedance amplifiers, fibre channel, HDD, SSD controller, storage accelerators, ASIC, and Marvell government solutions. It operates through the following geographical segments: United States, Singapore, Israel, India, China, and Others. The company was founded by Wei Li Dai and Pantas Sutardja in 1995 and is headquartered in Wilmington, DE.

Marvell Technology Inc

Marvell Technology is trending following reports that it is in talks with Google to develop custom AI chips, including a memory processing unit and an inference-optimized TPU. The community is actively discussing how this potential partnership, aimed at optimizing AI efficiency, positions Marvell as a key infrastructure player in a market shifting its focus from training to inference workloads.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals Corp. is trending as investors rally around the company's confirmed acquisition of a majority stake in the Tanbreez rare earth project, a key milestone that materially de-risks the asset and fuels speculation regarding future government investment and supply chain significance. The community is actively discussing the stock's potential for a massive short squeeze, with many pointing to heavy volume and limited borrow availability as signals that the stock is poised for significant upside.

MARA Holdings, Inc. is a digital asset technology company, which engages in mining cryptocurrencies with a focus on the Bitcoin ecosystem. It also deals with owning and operating bitcoin mining facilities or data centers, selling proprietary software or technology to third parties operating in the Bitcoin ecosystem, offering advisory and consulting services to support Bitcoin mining ventures in domestic and international jurisdictions, and generating electricity from renewable energy resources or methane gas capture to power Bitcoin mining projects. The company was founded on February 23, 2010 and is headquartered in Hallandale Beach, FL.

MARA Holdings Inc.

Marathon Digital Holdings Inc

Marathon Digital Holdings is currently a focal point for investors debating its transition from a pure-play Bitcoin miner to an AI infrastructure and power capacity operator. The community is actively tracking potential short squeeze dynamics, contrasting the stock's recent volatility and management criticism against bullish sentiment surrounding institutional accumulation and long-term infrastructure value.

Operates as a holding company with interest in providing social shopping platform solutions

WeShop Holdings Ltd - Ordinary Shares - Class A

WeShop Holdings Limited

WeShop Holdings is experiencing intense volatility as retail traders push the stock through significant intraday swings, drawing heavy attention to its low-float status and high short interest. While bulls are banking on a potential short squeeze and upcoming earnings catalysts, the community remains deeply divided, with many debating whether the rapid price movements signal real growth or are merely a classic pump-and-dump cycle.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bear 3X ETF

Direxion Daily Semiconductor Bear 3X Shares

Direxion Daily Semiconductor Bear 3X Shares (SOXS) is trending as frustrated investors discuss the relentless rally in semiconductor stocks, which has driven this leveraged bear ETF to new lows. The community is actively debating whether the current market environment is a parabolic blow-off top driven by AI exuberance and geopolitical distractions, or if they should continue averaging down in anticipation of a sharp sector pullback.

Compass Pathways Plc is a biotechnology company, which provides mental health care services. It focuses on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. The company was founded by Goldsmith George Jay and Malievskaia Ekaterina in 2016 and is headquartered in London, the United Kingdom.

Compass Pathways Plc - ADR

COMPASS Pathways

COMPASS Pathways is capturing significant market attention following a major executive order that prioritizes and fast-tracks the federal review and research of psychedelic-based treatments for mental health conditions. Investors and the community are actively debating the company's competitive advantage as a leader in Phase 3 psilocybin trials, with many closely monitoring potential regulatory tailwinds and the upcoming clinical data readouts.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is gaining intense investor attention as participants speculate on imminent data readouts from the REGAL Phase 3 trial and upcoming AACR conference presentations for SLS009. The community is deeply divided, with bulls pointing to extended survival signals and institutional positioning as catalysts for a potential squeeze, while bears highlight concerns over trial design and the company's long-term financial viability.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Wealth Enhancement Trust Services Inc. Takes Position in CRISPR Therapeutics AG $CRSP

Wealth Enhancement Trust Services Inc. purchased a new position in shares of CRISPR Therapeutics AG (NASDAQ:CRSP - Free Report) in the 4th quarter, according to the company in its most recent 13F...

CRISPR Therapeutics AG (NASDAQ:CRSP) Receives Average Rating of "Moderate Buy" from Brokerages

Shares of CRISPR Therapeutics AG (NASDAQ:CRSP - Get Free Report) have received a consensus rating of "Moderate Buy" from the nineteen analysts that are currently covering the firm, Marketbeat reports. Two research analysts have rated the stock with a sell rating, six have given a hold rating, ten h...

CRISPR Therapeutics AG (CRSP) Stock Sinks As Market Gains: What You Should Know

In the latest trading session, CRISPR Therapeutics AG (CRSP) closed at $55.72, marking a -1.83% move from the previous day.

Sumitomo Mitsui Trust Group Inc. Sells 205,564 Shares of CRISPR Therapeutics AG $CRSP

Sumitomo Mitsui Trust Group Inc. decreased its holdings in CRISPR Therapeutics AG (NASDAQ:CRSP - Free Report) by 9.5% during the fourth quarter, according to the company in its most recent disclosure...

CRISPR Therapeutics Touts Second Phase After Casgevy, Eyes 6 Data Readouts in 6 12 Months

CRISPR Therapeutics (NASDAQ:CRSP) CEO Sam Kulkarni told investors at the Needham Healthcare Conference that the company is moving into what he described as a second phase following the launch of...

2 Billion Reasons to Love CRISPR Therapeutics Right Now

Key PointsCRISPR Therapeutics is still losing money, but it has an expanding pipeline...

Three Best Genomics Stocks for Your Portfolio in 2026

Genomics gains momentum as breakthroughs, falling sequencing costs, and CRISPR advances drive precision medicine and fuel rapid market growth.

CRISPR Therapeutics AG (CRSP) is Attracting Investor Attention: Here is What You Should Know  

Zacks.com users have recently been watching CRISPR Therapeutics (CRSP) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Sutro Biopharma (STRO) Moves 7.4% Higher: Will This Strength Last?

Sutro Biopharma (STRO) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.

CRISPR Therapeutics AG (CRSP) Rises Higher Than Market: Key Facts

CRISPR Therapeutics AG (CRSP) closed the most recent trading day at $49.51, moving +1.43% from the previous trading session.

CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Its CRISPR/Cas9 platform is a gene editing technology that allows for precise, directed changes to genomic DNA. The firm offers a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine, and rare diseases. The company was founded by Rodger Novak, Emmanuelle Charpentier, Shaun Patrick Foy, Matthew Porteus, Daniel Anderson, Chad Cowan, and Craig Mellow on October 31, 2013 and is headquartered in Zug, Switzerland.

CRSP
CRISPR Therapeutics AG

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest CRSP News

CRSPCRISPR Therapeutics AG